Prytime Medical Devices, Inc. introduced its latest aortic occlusion catheter, the ER-REBOA™ PLUS this week at the American Association for the Surgery of Trauma (AAST) Annual Meeting.
Prytime Medical Devices notes it is designed for improved ease of use, it is REBOA refined for controlling massive non-compressible hemorrhage.
“The original ER-REBOA™ catheter was an important start in delivering a new technology to help clinicians stabilize and manage certain scenarios of bleeding and shock; a technology that, to date, has contributed to saving hundreds of lives,” said Col. (Dr.) Todd Rasmussen, Director of the Battlefield Shock and Resuscitation Research Program at the Uniformed Services University of the Health Sciences. “However, we recognized from the outset that the original design and device would evolve. Even iterative changes in the technology, such as with the ER-REBOA™ PLUS, stand to make the devices easier to use, safer and more effective.”
“ER-REBOA™ PLUS represents the evolution of REBOA based on experience and input from civilian trauma surgeons,” said David Spencer, CEO, Prytime. “The civilian marketplace believes that no one should bleed to death, and the sooner you stop the bleeding the better. The ER-REBOA™ PLUS catheter was developed to help doctors preserve their clinical options for optimal care and best outcomes.”
